Launxp Biomedical Co (ROCO:6876) Dividend Yield %: 0.00% (As of Jun. 28, 2026)


ROCO:6876 Launxp Biomedical Co Ltd ROCO:6876
11 GF Score
Price NT$15.90
! 4 Warning Signs
View Full Analysis

What is Launxp Biomedical Co Dividend Yield %?

Launxp Biomedical Co ROCO:6876 -0.93% 11 Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus rates ROCO:6876 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 153 Biotechnology companies, Launxp Biomedical Co ranks worse than 653594.12% on this metric.

As of today (2026-06-28), the Trailing Annual Dividend Yield of Launxp Biomedical Co is 0.00%.

The historical rank and industry rank for Launxp Biomedical Co's Dividend Yield % or its related term are showing as below:

ROCO:6876's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.57
* Ranked among companies with meaningful Dividend Yield % only.

Launxp Biomedical Co's Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00.

As of today (2026-06-28), the Forward Dividend Yield % of Launxp Biomedical Co is 0.00%.

Launxp Biomedical Co's Dividends per Share for the six months ended in Dec. 2025 was NT$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Launxp Biomedical Co  (ROCO:6876) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Launxp Biomedical Co Dividend Yield % Related Terms


Launxp Biomedical Co Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Launxp Biomedical Co's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Launxp Biomedical Co Dividend Yield % Chart

Launxp Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Launxp Biomedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROCO:6876 vs VRTX, REGN, ALNY: Dividend Yield % Comparison

For the Biotechnology subindustry, Launxp Biomedical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Launxp Biomedical Co Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Launxp Biomedical Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Launxp Biomedical Co's Dividend Yield % falls into.


ROCO:6876
11GF Score
Launxp Biomedical Co Ltd ROCO:6876
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Launxp Biomedical Co Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Launxp Biomedical Co (ROCO:6876) has a Dividend Yield % of 0.00% as of Jun. 28, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Launxp Biomedical Co and its competitors. According to the industry distribution chart, Launxp Biomedical Co ranks #999999 out of 153 companies in the Biotechnology industry.
Is Launxp Biomedical Co's Dividend Yield % too high?
Launxp Biomedical Co's current Dividend Yield % is 0.00%. Based on the distribution chart, Launxp Biomedical Co ranks #999999 out of 153 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Launxp Biomedical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Launxp Biomedical Co's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Launxp Biomedical Co ranks #999999 out of 153 companies for Dividend Yield %. This places Launxp Biomedical Co in the lower half of its industry. The industry median Dividend Yield % is 1.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.57, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Launxp Biomedical Co and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Launxp Biomedical Co's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Launxp Biomedical Co stock overvalued right now?
Launxp Biomedical Co (ROCO:6876) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Launxp Biomedical Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Launxp Biomedical Co (ROCO:6876), the current Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Launxp Biomedical Co Business Description

Address 10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408
Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.
11GF Score

Get the complete analysis for ROCO:6876

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.90
Price